Corpus Intelligence IC Memo — PRIMARY CHILDRENS HOSPITAL 2026-04-26 04:05 UTC
IC Memo — PRIMARY CHILDRENS HOSPITAL
Investment Committee Memorandum | UT | 287 beds | Grade B | EBITDA uplift $65.9M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

PRIMARY CHILDRENS HOSPITAL

CCN 463301 | SALT LAKE, UT | 287 beds | April 26, 2026
EBITDA BridgeData Room
B
Investability

1. Target Overview & Investment Thesis

PRIMARY CHILDRENS HOSPITAL is a 287-bed suburban community hospital in SALT LAKE, UT with $895.5M in net patient revenue and a 5.6% operating margin. The hospital serves a payer mix of 0.3% Medicare, 8.3% Medicaid, and 91.5% commercial.

Thesis: Platform Growth. Our ML models identify $65.9M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 5.6% to 13.0% (+736bps).

Net Revenue HCRIS$895.5M
Current EBITDA COMPUTED$50.3M
Operating Margin COMPUTED5.6%
Occupancy HCRIS77.0%
Revenue / Bed COMPUTED$3.1M
Net-to-Gross HCRIS58.8%
Distress Probability ML42.8%

2. Market Context & Competitive Position

59
UT Hospitals
8.0%
State Median Margin
10
Comparable Hospitals

UT has 59 Medicare-certified hospitals with a median operating margin of 8.0%. The target's margin of 5.6% places it below the state median. Among 10 size-comparable peers (144-574 beds), the median margin is 12.6%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (144-574), prioritizing same-state peers. 10 hospitals in the comp set.

HospitalStateBedsRevenueMargin
PRIMARY CHILDRENS HOSPITAL (Target)UT287$895.5M5.6%
INTERMOUNTAIN MEDICAL CENTERUT486$1.24B8.9%
ST GEORGE REGIONAL HOSPITALUT256$790.1M12.0%
UTAH VALLEY HOSPITALUT338$707.3M7.6%
MCKAY-DEE HOSPITALUT236$629.9M12.6%
ST MARKS HOSPITALUT263$539.0M44.0%
LDS HOSPITALUT216$307.0M-5.5%
OGDEN REGIONAL MEDICAL CENTERUT174$299.3M47.4%
JORDAN VALLEY MEDICAL CENTERUT267$274.2M17.2%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $65.9M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$18.8M+210bp18mo
Cost to Collect4.5%2.5%$17.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$17.7M+198bp12mo
A/R Days Reduction5200.0%3800.0%$10.9M+122bp9mo
Clean Claim Rate88.0%96.0%$573K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$18.8M
Cost to Collect
$17.9M
Denial Rate Reduction
$17.7M
A/R Days Reduction
$10.9M
Clean Claim Rate
$573K
Total EBITDA Uplift$65.9M
Current EBITDA$50.3M
+ RCM Uplift+$65.9M
Pro Forma EBITDA$116.2M
Current Margin5.6%
Pro Forma Margin13.0%
WC Released (1x)$34.3M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$77.3M$990.7M12.81x66.5%
Base (11x exit)10.0x11.0x$77.3M$1.11B14.42x70.5%
Bull Case9.0x11.0x$69.6M$1.36B19.51x81.2%
Bull (12x exit)9.0x12.0x$69.6M$1.50B21.58x84.8%
Bear Case11.0x10.0x$85.0M$636.0M7.48x49.5%
Bear (11x exit)11.0x11.0x$85.0M$727.2M8.55x53.6%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumStandard execution riskRCM improvement requires management buy-in and 12-18 month implementation timeline

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 10 hospitals with 144-574 beds
  • Same-state prioritization (n=11)
  • Comp margins: P25=8.9% / P50=12.6% / P75=29.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.